What is China Medical System Holdings Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. China Medical System Holdings's pretax income for the
six
months ended in Dec. 2023 was HK$647 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,143 Mil.
China Medical System Holdings's pretax margin was 17.37%.
During the past 13 years, China Medical System Holdings's highest Pretax Margin was 41.46%. The lowest was 29.95%. And the median was 37.64%.
China Medical System Holdings Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Medical System Holdings Pre-Tax Income Chart
Competitive Comparison of China Medical System Holdings's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical System Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's Pre-Tax Income falls into.
China Medical System Holdings Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3,143 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical System Holdings (HKSE:00867) Pre-Tax Income Explanation
China Medical System Holdings's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, China Medical System Holdings's highest Pretax Margin was 41.46%. The lowest was 29.95%. And the median was 37.64%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical System Holdings Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of China Medical System Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
China Medical System Holdings (HKSE:00867) Business Description
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00867 has been successfully added to your 